+91 9822601479

Skin cancers can arise from different types of cells in the upper layers of the skin and can be situated on any part of the skin. Squamous cell carcinoma, basal cell carcinoma, and melanoma are the commonly found different histological types of skin cancers. Skin cancer Treatment in pune is available with dr. amit parasnis.

Squamous cell carcinomas develop in the skin in areas that face constant irritation or multiple trauma. Such cancers are found in the skin of the groin, flank, and axilla or in chronic burn scars and non-healing wounds. They present as ulcer-proliferative growths which may be painful, bleed on touch and spread to local and regional lymph nodes.

Basal cell carcinomas are commonly found on the face. They typically present as circular ulcers with rounded edges which display slow growth over a long period of time. They do not spread to lymph node but they bury into and cause ulceration of the underlying tissues.

Melanomas are one of the most aggressive and dangerous skin cancers and they are often found in fair-skinned people. Uncontrolled exposure to ultra-violet rays of the sunlight are often considered to be the etiology of melanomas. They will typically present as hyperpigmented or black spots in the exposed areas of the skin. They have a high propensity towards early and distant metastases which makes them life-threatening if not detected and treated early.

Skin Cancer Treatment in Pune consists of wide excision of the growth along with adjacent involved tissues and lymph nodes ensuring wide margins. This is often required to be accompanied by reconstruction of the area by appropriate reconstructive and plastic surgery techniques.

In squamous cell carcinomas, additional radiotherapy for Skin Cancer Treatment is given to node-positive and large tumors to achieve local control and prevent metastases.

Dr. Amit Parasnis is a well-trained and experienced cancer surgeon for Skin Cancer Treatment in Pune who provides rational and ethical treatment for cancer and strives to achieve best oncological outcomes.